Qingyu Luo

903 total citations
21 papers, 540 citations indexed

About

Qingyu Luo is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Qingyu Luo has authored 21 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Qingyu Luo's work include Ubiquitin and proteasome pathways (7 papers), Cancer Mechanisms and Therapy (4 papers) and Chromatin Remodeling and Cancer (4 papers). Qingyu Luo is often cited by papers focused on Ubiquitin and proteasome pathways (7 papers), Cancer Mechanisms and Therapy (4 papers) and Chromatin Remodeling and Cancer (4 papers). Qingyu Luo collaborates with scholars based in China, United States and Australia. Qingyu Luo's co-authors include Xiaowei Wu, Zhihua Liu, Pengfei Zhao, Wan Chang, Yabing Nan, Tong Shu, Fang Ding, Dan Su, Yating Wang and Xiaolin Zhu and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Qingyu Luo

19 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qingyu Luo China	15	425	162	128	64	52	21	540
Antonio Lucena-Cacace Spain	14	365 0.9×	261 1.6×	104 0.8×	64 1.0×	78 1.5×	23	598
Joan Fernando Spain	7	334 0.8×	192 1.2×	128 1.0×	58 0.9×	42 0.8×	8	532
Xi Cheng China	12	348 0.8×	143 0.9×	232 1.8×	46 0.7×	35 0.7×	18	531
Yao-Chen Wang Taiwan	11	345 0.8×	152 0.9×	136 1.1×	37 0.6×	33 0.6×	13	489
Dongyi Wan China	10	326 0.8×	153 0.9×	146 1.1×	33 0.5×	31 0.6×	16	481
Eun Ji Ro South Korea	10	412 1.0×	265 1.6×	102 0.8×	81 1.3×	34 0.7×	12	633
Georg Machat Austria	4	279 0.7×	144 0.9×	113 0.9×	54 0.8×	26 0.5×	4	416
Lubna Qamar United States	13	397 0.9×	117 0.7×	195 1.5×	30 0.5×	61 1.2×	20	557
Shi‐Juan Mai China	15	375 0.9×	133 0.8×	225 1.8×	51 0.8×	53 1.0×	32	572

Countries citing papers authored by Qingyu Luo

Since Specialization

Citations

This map shows the geographic impact of Qingyu Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyu Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyu Luo more than expected).

Fields of papers citing papers by Qingyu Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingyu Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyu Luo. The network helps show where Qingyu Luo may publish in the future.

Co-authorship network of co-authors of Qingyu Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Qingyu Luo. A scholar is included among the top collaborators of Qingyu Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyu Luo. Qingyu Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luo, Qingyu, et al.. (2025). PI3Kγ in leukemia: class IB PI3 kinase reemerges as a cancer-intrinsic target. Blood. 145(25). 2945–2953.

Yang, Mengqi, et al.. (2025). Human papillomavirus (HPV) infection and prevalence of colorectal cancer: an updated systematic review and meta-analysis of global data. International Journal of Surgery. 112(1). 1815–1825.

Nan, Yabing, Xiaowei Wu, Qingyu Luo, et al.. (2024). OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition. Proceedings of the National Academy of Sciences. 121(19). e2315348121–e2315348121. 12 indexed citations

Luo, Qingyu, Miguel A. Prado, Xiaowei Wu, et al.. (2024). Targetable leukaemia dependency on noncanonical PI3Kγ signalling. Nature. 630(8015). 198–205. 17 indexed citations

Nan, Yabing, Qingyu Luo, Xiaowei Wu, et al.. (2023). m6A demethylase FTO stabilizes LINK-A to exert oncogenic roles via MCM3-mediated cell-cycle progression and HIF-1α activation. Cell Reports. 42(10). 113273–113273. 15 indexed citations

Zhao, Pengfei, Qingyu Luo, Xiaowei Wu, et al.. (2023). RUNX1-IT1 acts as a scaffold of STAT1 and NuRD complex to promote ROS-mediated NF-κB activation and ovarian cancer progression. Oncogene. 43(6). 420–433. 9 indexed citations

Nan, Yabing, Qingyu Luo, Xiaowei Wu, et al.. (2022). HCP5 prevents ubiquitination-mediated UTP3 degradation to inhibit apoptosis by activating c-Myc transcriptional activity. Molecular Therapy. 31(2). 552–568. 23 indexed citations

Nan, Yabing, Qingyu Luo, Xiaowei Wu, et al.. (2022). DLGAP1-AS2–Mediated Phosphatidic Acid Synthesis Activates YAP Signaling and Confers Chemoresistance in Squamous Cell Carcinoma. Cancer Research. 82(16). 2887–2903. 19 indexed citations

Chang, Wan, Qingyu Luo, Xiaowei Wu, et al.. (2022). OTUB2 exerts tumor-suppressive roles via STAT1-mediated CALML3 activation and increased phosphatidylserine synthesis. Cell Reports. 41(4). 111561–111561. 28 indexed citations

10.

Luo, Qingyu, Yuanqiu Li, Qingguo Xie, et al.. (2022). Volumetric visceral fat machine learning phenotype on CT for differential diagnosis of inflammatory bowel disease. European Radiology. 33(3). 1862–1872. 19 indexed citations

11.

Wang, Xiaowei, et al.. (2022). The clinical efficacy of collagen dressing on chronic wounds: A meta-analysis of 11 randomized controlled trials. Frontiers in Surgery. 9. 978407–978407. 11 indexed citations

12.

Luo, Qingyu, Xiaowei Wu, Pengfei Zhao, et al.. (2021). OTUD1 Activates Caspase‐Independent and Caspase‐Dependent Apoptosis by Promoting AIF Nuclear Translocation and MCL1 Degradation. Advanced Science. 8(8). 2002874–2002874. 55 indexed citations

13.

Luo, Qingyu, Xiaowei Wu, & Zhihua Liu. (2020). Remodeling of the ARID1A tumor suppressor. Cancer Letters. 491. 1–10. 9 indexed citations

14.

Wu, Xiaowei, Qingyu Luo, & Zhihua Liu. (2020). Ubiquitination and deubiquitination of MCL1 in cancer: deciphering chemoresistance mechanisms and providing potential therapeutic options. Cell Death and Disease. 11(7). 556–556. 59 indexed citations

15.

Luo, Qingyu, Xiaowei Wu, Yabing Nan, et al.. (2020). TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma. Cell Reports. 30(1). 98–111.e5. 40 indexed citations

16.

Qin, Xuan, et al.. (2020). Downregulation of the GLP-1/CREB/adiponectin pathway is partially responsible for diabetes-induced dysregulated vascular tone and VSMC dysfunction. Biomedicine & Pharmacotherapy. 127. 110218–110218. 19 indexed citations

17.

Luo, Qingyu, Xiaowei Wu, Wan Chang, et al.. (2019). ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb/E2F1/c-Myc-mediated cancer stemness. Cell Death and Differentiation. 27(6). 1981–1997. 35 indexed citations

18.

Wu, Xiaowei, Qingyu Luo, Pengfei Zhao, et al.. (2019). JOSD1 inhibits mitochondrial apoptotic signalling to drive acquired chemoresistance in gynaecological cancer by stabilizing MCL1. Cell Death and Differentiation. 27(1). 55–70. 54 indexed citations

19.

Zhang, Yiping, Furong Huang, Qingyu Luo, et al.. (2018). Inhibition of XIAP increases carboplatin sensitivity in ovarian cancer. OncoTargets and Therapy. Volume 11. 8751–8759. 17 indexed citations

20.

Luo, Qingyu, Xiaowei Wu, Yiping Zhang, et al.. (2018). ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2. Cancer Letters. 427. 9–17. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact